different law firm, however, he seems to lead to Swartz. Is Swartz somehow involved in the TPL litigation?

Old news but interesting connection

Meditech Pharmaceuticals, Inc.
10105 E. Via Linda #103, PMB 382,
Phoenix, Arizona 85258
(480) 614-2874
(Name, address and telephone number of agent for service) Copies to:
Mark Ziebell, Esq.
Jeffers, Shaff & Falk, LLP
18881 Von Karman Avenue, Suite 1400
Irvine, California 92612

The Resale of 73,116,000 Shares of Common Stock

o This prospectus relates to the resale by the selling shareholders of up to 73,116,000 shares of our common stock. The selling shareholders may sell the stock from time to time in the over-the-counter market at the prevailing market price or in negotiated transactions. Of the shares we are registering, Swartz Private Equity, LLC, one of the selling shareholders, may acquire up to 47,000,000 shares under the equity line agreement with our Company. Swartz is an underwriter with respect to these shares.

Our common stock is quoted on the over-the counter electronic bulletin board under the symbol "MDCH.OB." On March 22, 2001, the average of the bid and asked prices of our common stock was $0.163 per share.

About our Investment Agreement

We have entered into an investment agreement with Swartz to raise up to $30 million through a series of sales of our common stock to Swartz. The dollar amount of each sale is limited by our common stock's trading volume. A minimum period of time must occur between sales. In turn, Swartz will sell our stock in the open market, sell our stock to other investors through negotiated transactions or hold our common stock in its own portfolio. This prospectus covers Swartz's resale of our common either in the open market or to other investors.

Here is the link if you want to read how the Swartz deal was structured for Meditech

http://yahoo.brand.edgar-online.com/DisplayFilingInfo.aspx?Type=HTML&text=%2526lt%253bNEAR%252f4%2526gt%253b(%22LESTER+F.%22%2c%22GOLDSTEIN%22)&FilingID=1438722&ppu=%2fPeopleFilingResults.aspx%3fPersonID%3d2541385%26PersonName%3dLESTER%2520F.%2520GOLDSTEI

FORM SB-2

Meditech Pharmaceuticals, Inc.
10105 E. Via Linda #103, PMB 382,
Phoenix, Arizona 85258
(480) 614-2874
(Name, address and telephone number of agent for service) Copies to:
Mark Ziebell, Esq.
Jeffers, Shaff & Falk, LLP
18881 Von Karman Avenue, Suite 1400
Irvine, California 92612

http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHTML1?ID=25465&SessionID=HU9xHFiwbTb45m7